Thomas Rosenquist

Thomas Rosenquist is a Research Associate Professor in the Department of Pharmacological Sciences at Stony Brook University's Renaissance School of Medicine. His research focuses on DNA damage repair mechanisms, particularly in the context of environmental carcinogens like aristolochic acid, and developing biomarkers for cancer prevention and exposure assessment.

His educational background includes:

• Ph.D. from the University of Wisconsin-Madison
• Postdoctoral training at the University of California, San Francisco

Dr. Rosenquist's research centers on the genetic analysis of mammalian oxidative DNA damage repair. He investigates how environmental chemicals induce DNA damage that leads to cancer, with a focus on aristolochic acid. His work develops platforms linking DNA adducts to mutational signatures, utilizing adductomics and next-generation sequencing to identify exposure biomarkers and understand carcinogenesis processes.

Analysis of his recent publications (2016-2021) reveals a strong focus on DNA adduct detection methods, mutational signatures in cancer, and the role of environmental carcinogens in urological cancers. The research spans analytical chemistry, toxicology, and cancer epidemiology, emphasizing non-invasive biomarker development for early cancer detection.

Dr. Rosenquist collaborates with researchers at the University of Minnesota on adductomics. His interdisciplinary work involves teams in toxicology, oncology, and analytical chemistry to advance the understanding of environmental carcinogenesis.

No information is available regarding current advisees or grant funding.